Vivos Therapeutics DNA oral device gets FDA nod for obstructive sleep apnea
Vivos Therapeutics has secured the US Food and Drug Administration (FDA) 510(k) clearance for its DNA oral device indicated for obstructive sleep apnea (OSA) treatment. The 510(k) approval for the DNA appliance as a Class II device marks the third FDA clearance for Vivos’ oral devices and the first clearance for the medical technology company’s […]